Global Alzheimer's Disease Blood Diagnostic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Alzheimer's Disease (AD) blood diagnostic refers to a clinical test or series of tests that analyze specific biomarkers present in the blood to identify and diagnose Alzheimer's Disease. These diagnostics aim to detect the presence of pathological changes associated with AD, such as amyloid plaques, tau tangles, neurodegeneration, and other related abnormalities, using minimally invasive blood samples.
Alzheimer's Disease blood diagnostics represent a promising advancement in the field of neurodegenerative disease detection. By leveraging specific biomarkers and advanced analytical techniques, these tests offer a non-invasive, accessible, and potentially cost-effective means of diagnosing and monitoring Alzheimer's Disease, ultimately improving patient outcomes through earlier and more accurate diagnosis.
The global Alzheimer's Disease Blood Diagnostic market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Alzheimer's Disease Blood Diagnostic Industry Forecast” looks at past sales and reviews total world Alzheimer's Disease Blood Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Alzheimer's Disease Blood Diagnostic sales for 2023 through 2029. With Alzheimer's Disease Blood Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alzheimer's Disease Blood Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Alzheimer's Disease Blood Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Alzheimer's Disease Blood Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alzheimer's Disease Blood Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alzheimer's Disease Blood Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alzheimer's Disease Blood Diagnostic.
United States market for Alzheimer's Disease Blood Diagnostic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Alzheimer's Disease Blood Diagnostic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Alzheimer's Disease Blood Diagnostic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Alzheimer's Disease Blood Diagnostic players cover Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease Blood Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Alzheimer's Disease (AD) blood diagnostic refers to a clinical test or series of tests that analyze specific biomarkers present in the blood to identify and diagnose Alzheimer's Disease. These diagnostics aim to detect the presence of pathological changes associated with AD, such as amyloid plaques, tau tangles, neurodegeneration, and other related abnormalities, using minimally invasive blood samples.
Alzheimer's Disease blood diagnostics represent a promising advancement in the field of neurodegenerative disease detection. By leveraging specific biomarkers and advanced analytical techniques, these tests offer a non-invasive, accessible, and potentially cost-effective means of diagnosing and monitoring Alzheimer's Disease, ultimately improving patient outcomes through earlier and more accurate diagnosis.
The global Alzheimer's Disease Blood Diagnostic market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Alzheimer's Disease Blood Diagnostic Industry Forecast” looks at past sales and reviews total world Alzheimer's Disease Blood Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Alzheimer's Disease Blood Diagnostic sales for 2023 through 2029. With Alzheimer's Disease Blood Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alzheimer's Disease Blood Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Alzheimer's Disease Blood Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Alzheimer's Disease Blood Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alzheimer's Disease Blood Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alzheimer's Disease Blood Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alzheimer's Disease Blood Diagnostic.
United States market for Alzheimer's Disease Blood Diagnostic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Alzheimer's Disease Blood Diagnostic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Alzheimer's Disease Blood Diagnostic is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Alzheimer's Disease Blood Diagnostic players cover Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease Blood Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Amyloid Beta (A?)
- Tau Proteins
- Others
- Early Diagnosis
- Clinical Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amyloid Beta (A?)
- Tau Proteins
- Others
- Early Diagnosis
- Clinical Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Quanterix
- C2N Diagnostics
- Sysmex
- Quest Diagnostics
- Roche Diagnostics
- Eli Lilly and Company
- Fujirebio
- Amoneta Diagnostics
- MagQu
- Vazyme
- KingMed Diagnostics
- Anqun Bioengineering
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alzheimer's Disease Blood Diagnostic Market Size 2019-2030
2.1.2 Alzheimer's Disease Blood Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Alzheimer's Disease Blood Diagnostic by Country/Region, 2019, 2023 & 2030
2.2 Alzheimer's Disease Blood Diagnostic Segment by Type
2.2.1 Amyloid Beta (A?)
2.2.2 Tau Proteins
2.2.3 Others
2.3 Alzheimer's Disease Blood Diagnostic Market Size by Type
2.3.1 Alzheimer's Disease Blood Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Alzheimer's Disease Blood Diagnostic Segment by Application
2.4.1 Early Diagnosis
2.4.2 Clinical Research
2.5 Alzheimer's Disease Blood Diagnostic Market Size by Application
2.5.1 Alzheimer's Disease Blood Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
3 ALZHEIMER'S DISEASE BLOOD DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Alzheimer's Disease Blood Diagnostic Market Size Market Share by Player
3.1.1 Global Alzheimer's Disease Blood Diagnostic Revenue by Player (2019-2024)
3.1.2 Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Player (2019-2024)
3.2 Global Alzheimer's Disease Blood Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALZHEIMER'S DISEASE BLOOD DIAGNOSTIC BY REGION
4.1 Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024)
4.2 Global Alzheimer's Disease Blood Diagnostic Annual Revenue by Country/Region (2019-2024)
4.3 Americas Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
4.4 APAC Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
4.5 Europe Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
4.6 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)
5.2 Americas Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
5.3 Americas Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024)
6.2 APAC Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
6.3 APAC Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)
7.2 Europe Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
7.3 Europe Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alzheimer's Disease Blood Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALZHEIMER'S DISEASE BLOOD DIAGNOSTIC MARKET FORECAST
10.1 Global Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.1.1 Global Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.1.2 Americas Alzheimer's Disease Blood Diagnostic Forecast
10.1.3 APAC Alzheimer's Disease Blood Diagnostic Forecast
10.1.4 Europe Alzheimer's Disease Blood Diagnostic Forecast
10.1.5 Middle East & Africa Alzheimer's Disease Blood Diagnostic Forecast
10.2 Americas Alzheimer's Disease Blood Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Market Alzheimer's Disease Blood Diagnostic Forecast
10.2.2 Canada Market Alzheimer's Disease Blood Diagnostic Forecast
10.2.3 Mexico Market Alzheimer's Disease Blood Diagnostic Forecast
10.2.4 Brazil Market Alzheimer's Disease Blood Diagnostic Forecast
10.3 APAC Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.3.1 China Alzheimer's Disease Blood Diagnostic Market Forecast
10.3.2 Japan Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.3 Korea Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.4 Southeast Asia Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.5 India Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.6 Australia Market Alzheimer's Disease Blood Diagnostic Forecast
10.4 Europe Alzheimer's Disease Blood Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.2 France Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.3 UK Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.4 Italy Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.5 Russia Market Alzheimer's Disease Blood Diagnostic Forecast
10.5 Middle East & Africa Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Market Alzheimer's Disease Blood Diagnostic Forecast
10.5.2 South Africa Market Alzheimer's Disease Blood Diagnostic Forecast
10.5.3 Israel Market Alzheimer's Disease Blood Diagnostic Forecast
10.5.4 Turkey Market Alzheimer's Disease Blood Diagnostic Forecast
10.6 Global Alzheimer's Disease Blood Diagnostic Forecast by Type (2025-2030)
10.7 Global Alzheimer's Disease Blood Diagnostic Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Alzheimer's Disease Blood Diagnostic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Quanterix
11.1.1 Quanterix Company Information
11.1.2 Quanterix Alzheimer's Disease Blood Diagnostic Product Offered
11.1.3 Quanterix Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Quanterix Main Business Overview
11.1.5 Quanterix Latest Developments
11.2 C2N Diagnostics
11.2.1 C2N Diagnostics Company Information
11.2.2 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.2.3 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 C2N Diagnostics Main Business Overview
11.2.5 C2N Diagnostics Latest Developments
11.3 Sysmex
11.3.1 Sysmex Company Information
11.3.2 Sysmex Alzheimer's Disease Blood Diagnostic Product Offered
11.3.3 Sysmex Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sysmex Main Business Overview
11.3.5 Sysmex Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.4.3 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Information
11.5.2 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.5.3 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Diagnostics Main Business Overview
11.5.5 Roche Diagnostics Latest Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Information
11.6.2 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product Offered
11.6.3 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eli Lilly and Company Main Business Overview
11.6.5 Eli Lilly and Company Latest Developments
11.7 Fujirebio
11.7.1 Fujirebio Company Information
11.7.2 Fujirebio Alzheimer's Disease Blood Diagnostic Product Offered
11.7.3 Fujirebio Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fujirebio Main Business Overview
11.7.5 Fujirebio Latest Developments
11.8 Amoneta Diagnostics
11.8.1 Amoneta Diagnostics Company Information
11.8.2 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.8.3 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amoneta Diagnostics Main Business Overview
11.8.5 Amoneta Diagnostics Latest Developments
11.9 MagQu
11.9.1 MagQu Company Information
11.9.2 MagQu Alzheimer's Disease Blood Diagnostic Product Offered
11.9.3 MagQu Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MagQu Main Business Overview
11.9.5 MagQu Latest Developments
11.10 Vazyme
11.10.1 Vazyme Company Information
11.10.2 Vazyme Alzheimer's Disease Blood Diagnostic Product Offered
11.10.3 Vazyme Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Vazyme Main Business Overview
11.10.5 Vazyme Latest Developments
11.11 KingMed Diagnostics
11.11.1 KingMed Diagnostics Company Information
11.11.2 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.11.3 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 KingMed Diagnostics Main Business Overview
11.11.5 KingMed Diagnostics Latest Developments
11.12 Anqun Bioengineering
11.12.1 Anqun Bioengineering Company Information
11.12.2 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product Offered
11.12.3 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Anqun Bioengineering Main Business Overview
11.12.5 Anqun Bioengineering Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alzheimer's Disease Blood Diagnostic Market Size 2019-2030
2.1.2 Alzheimer's Disease Blood Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Alzheimer's Disease Blood Diagnostic by Country/Region, 2019, 2023 & 2030
2.2 Alzheimer's Disease Blood Diagnostic Segment by Type
2.2.1 Amyloid Beta (A?)
2.2.2 Tau Proteins
2.2.3 Others
2.3 Alzheimer's Disease Blood Diagnostic Market Size by Type
2.3.1 Alzheimer's Disease Blood Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Alzheimer's Disease Blood Diagnostic Segment by Application
2.4.1 Early Diagnosis
2.4.2 Clinical Research
2.5 Alzheimer's Disease Blood Diagnostic Market Size by Application
2.5.1 Alzheimer's Disease Blood Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
3 ALZHEIMER'S DISEASE BLOOD DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Alzheimer's Disease Blood Diagnostic Market Size Market Share by Player
3.1.1 Global Alzheimer's Disease Blood Diagnostic Revenue by Player (2019-2024)
3.1.2 Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Player (2019-2024)
3.2 Global Alzheimer's Disease Blood Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALZHEIMER'S DISEASE BLOOD DIAGNOSTIC BY REGION
4.1 Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024)
4.2 Global Alzheimer's Disease Blood Diagnostic Annual Revenue by Country/Region (2019-2024)
4.3 Americas Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
4.4 APAC Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
4.5 Europe Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
4.6 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)
5.2 Americas Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
5.3 Americas Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024)
6.2 APAC Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
6.3 APAC Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)
7.2 Europe Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
7.3 Europe Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alzheimer's Disease Blood Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALZHEIMER'S DISEASE BLOOD DIAGNOSTIC MARKET FORECAST
10.1 Global Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.1.1 Global Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.1.2 Americas Alzheimer's Disease Blood Diagnostic Forecast
10.1.3 APAC Alzheimer's Disease Blood Diagnostic Forecast
10.1.4 Europe Alzheimer's Disease Blood Diagnostic Forecast
10.1.5 Middle East & Africa Alzheimer's Disease Blood Diagnostic Forecast
10.2 Americas Alzheimer's Disease Blood Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Market Alzheimer's Disease Blood Diagnostic Forecast
10.2.2 Canada Market Alzheimer's Disease Blood Diagnostic Forecast
10.2.3 Mexico Market Alzheimer's Disease Blood Diagnostic Forecast
10.2.4 Brazil Market Alzheimer's Disease Blood Diagnostic Forecast
10.3 APAC Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.3.1 China Alzheimer's Disease Blood Diagnostic Market Forecast
10.3.2 Japan Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.3 Korea Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.4 Southeast Asia Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.5 India Market Alzheimer's Disease Blood Diagnostic Forecast
10.3.6 Australia Market Alzheimer's Disease Blood Diagnostic Forecast
10.4 Europe Alzheimer's Disease Blood Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.2 France Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.3 UK Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.4 Italy Market Alzheimer's Disease Blood Diagnostic Forecast
10.4.5 Russia Market Alzheimer's Disease Blood Diagnostic Forecast
10.5 Middle East & Africa Alzheimer's Disease Blood Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Market Alzheimer's Disease Blood Diagnostic Forecast
10.5.2 South Africa Market Alzheimer's Disease Blood Diagnostic Forecast
10.5.3 Israel Market Alzheimer's Disease Blood Diagnostic Forecast
10.5.4 Turkey Market Alzheimer's Disease Blood Diagnostic Forecast
10.6 Global Alzheimer's Disease Blood Diagnostic Forecast by Type (2025-2030)
10.7 Global Alzheimer's Disease Blood Diagnostic Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Alzheimer's Disease Blood Diagnostic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Quanterix
11.1.1 Quanterix Company Information
11.1.2 Quanterix Alzheimer's Disease Blood Diagnostic Product Offered
11.1.3 Quanterix Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Quanterix Main Business Overview
11.1.5 Quanterix Latest Developments
11.2 C2N Diagnostics
11.2.1 C2N Diagnostics Company Information
11.2.2 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.2.3 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 C2N Diagnostics Main Business Overview
11.2.5 C2N Diagnostics Latest Developments
11.3 Sysmex
11.3.1 Sysmex Company Information
11.3.2 Sysmex Alzheimer's Disease Blood Diagnostic Product Offered
11.3.3 Sysmex Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sysmex Main Business Overview
11.3.5 Sysmex Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.4.3 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Information
11.5.2 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.5.3 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Diagnostics Main Business Overview
11.5.5 Roche Diagnostics Latest Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Information
11.6.2 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product Offered
11.6.3 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eli Lilly and Company Main Business Overview
11.6.5 Eli Lilly and Company Latest Developments
11.7 Fujirebio
11.7.1 Fujirebio Company Information
11.7.2 Fujirebio Alzheimer's Disease Blood Diagnostic Product Offered
11.7.3 Fujirebio Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fujirebio Main Business Overview
11.7.5 Fujirebio Latest Developments
11.8 Amoneta Diagnostics
11.8.1 Amoneta Diagnostics Company Information
11.8.2 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.8.3 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amoneta Diagnostics Main Business Overview
11.8.5 Amoneta Diagnostics Latest Developments
11.9 MagQu
11.9.1 MagQu Company Information
11.9.2 MagQu Alzheimer's Disease Blood Diagnostic Product Offered
11.9.3 MagQu Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MagQu Main Business Overview
11.9.5 MagQu Latest Developments
11.10 Vazyme
11.10.1 Vazyme Company Information
11.10.2 Vazyme Alzheimer's Disease Blood Diagnostic Product Offered
11.10.3 Vazyme Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Vazyme Main Business Overview
11.10.5 Vazyme Latest Developments
11.11 KingMed Diagnostics
11.11.1 KingMed Diagnostics Company Information
11.11.2 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
11.11.3 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 KingMed Diagnostics Main Business Overview
11.11.5 KingMed Diagnostics Latest Developments
11.12 Anqun Bioengineering
11.12.1 Anqun Bioengineering Company Information
11.12.2 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product Offered
11.12.3 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Anqun Bioengineering Main Business Overview
11.12.5 Anqun Bioengineering Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alzheimer's Disease Blood Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Alzheimer's Disease Blood Diagnostic Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Amyloid Beta (A?)
Table 4. Major Players of Tau Proteins
Table 5. Major Players of Others
Table 6. Alzheimer's Disease Blood Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Table 9. Alzheimer's Disease Blood Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Table 12. Global Alzheimer's Disease Blood Diagnostic Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Player (2019-2024)
Table 14. Alzheimer's Disease Blood Diagnostic Key Players Head office and Products Offered
Table 15. Alzheimer's Disease Blood Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Table 20. Global Alzheimer's Disease Blood Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Alzheimer's Disease Blood Diagnostic Market Size Market Share by Country (2019-2024)
Table 24. Americas Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Table 26. Americas Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Table 28. APAC Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Table 30. APAC Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Country (2019-2024)
Table 34. Europe Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Alzheimer's Disease Blood Diagnostic
Table 40. Key Market Challenges & Risks of Alzheimer's Disease Blood Diagnostic
Table 41. Key Industry Trends of Alzheimer's Disease Blood Diagnostic
Table 42. Global Alzheimer's Disease Blood Diagnostic Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Alzheimer's Disease Blood Diagnostic Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Alzheimer's Disease Blood Diagnostic Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Quanterix Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 47. Quanterix Alzheimer's Disease Blood Diagnostic Product Offered
Table 48. Quanterix Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Quanterix Main Business
Table 50. Quanterix Latest Developments
Table 51. C2N Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 52. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 53. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. C2N Diagnostics Main Business
Table 55. C2N Diagnostics Latest Developments
Table 56. Sysmex Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 57. Sysmex Alzheimer's Disease Blood Diagnostic Product Offered
Table 58. Sysmex Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Sysmex Main Business
Table 60. Sysmex Latest Developments
Table 61. Quest Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 62. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 63. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Quest Diagnostics Main Business
Table 65. Quest Diagnostics Latest Developments
Table 66. Roche Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 67. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 68. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Roche Diagnostics Main Business
Table 70. Roche Diagnostics Latest Developments
Table 71. Eli Lilly and Company Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 72. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product Offered
Table 73. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Eli Lilly and Company Main Business
Table 75. Eli Lilly and Company Latest Developments
Table 76. Fujirebio Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 77. Fujirebio Alzheimer's Disease Blood Diagnostic Product Offered
Table 78. Fujirebio Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Fujirebio Main Business
Table 80. Fujirebio Latest Developments
Table 81. Amoneta Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 82. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 83. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Amoneta Diagnostics Main Business
Table 85. Amoneta Diagnostics Latest Developments
Table 86. MagQu Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 87. MagQu Alzheimer's Disease Blood Diagnostic Product Offered
Table 88. MagQu Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. MagQu Main Business
Table 90. MagQu Latest Developments
Table 91. Vazyme Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 92. Vazyme Alzheimer's Disease Blood Diagnostic Product Offered
Table 93. Vazyme Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Vazyme Main Business
Table 95. Vazyme Latest Developments
Table 96. KingMed Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 97. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 98. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. KingMed Diagnostics Main Business
Table 100. KingMed Diagnostics Latest Developments
Table 101. Anqun Bioengineering Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 102. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product Offered
Table 103. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Anqun Bioengineering Main Business
Table 105. Anqun Bioengineering Latest Developments
Table 1. Alzheimer's Disease Blood Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Alzheimer's Disease Blood Diagnostic Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Amyloid Beta (A?)
Table 4. Major Players of Tau Proteins
Table 5. Major Players of Others
Table 6. Alzheimer's Disease Blood Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Table 9. Alzheimer's Disease Blood Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Table 12. Global Alzheimer's Disease Blood Diagnostic Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Player (2019-2024)
Table 14. Alzheimer's Disease Blood Diagnostic Key Players Head office and Products Offered
Table 15. Alzheimer's Disease Blood Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Table 20. Global Alzheimer's Disease Blood Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Alzheimer's Disease Blood Diagnostic Market Size Market Share by Country (2019-2024)
Table 24. Americas Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Table 26. Americas Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Table 28. APAC Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Table 30. APAC Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Country (2019-2024)
Table 34. Europe Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Alzheimer's Disease Blood Diagnostic
Table 40. Key Market Challenges & Risks of Alzheimer's Disease Blood Diagnostic
Table 41. Key Industry Trends of Alzheimer's Disease Blood Diagnostic
Table 42. Global Alzheimer's Disease Blood Diagnostic Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Alzheimer's Disease Blood Diagnostic Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Alzheimer's Disease Blood Diagnostic Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Quanterix Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 47. Quanterix Alzheimer's Disease Blood Diagnostic Product Offered
Table 48. Quanterix Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Quanterix Main Business
Table 50. Quanterix Latest Developments
Table 51. C2N Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 52. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 53. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. C2N Diagnostics Main Business
Table 55. C2N Diagnostics Latest Developments
Table 56. Sysmex Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 57. Sysmex Alzheimer's Disease Blood Diagnostic Product Offered
Table 58. Sysmex Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Sysmex Main Business
Table 60. Sysmex Latest Developments
Table 61. Quest Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 62. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 63. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Quest Diagnostics Main Business
Table 65. Quest Diagnostics Latest Developments
Table 66. Roche Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 67. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 68. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Roche Diagnostics Main Business
Table 70. Roche Diagnostics Latest Developments
Table 71. Eli Lilly and Company Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 72. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product Offered
Table 73. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Eli Lilly and Company Main Business
Table 75. Eli Lilly and Company Latest Developments
Table 76. Fujirebio Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 77. Fujirebio Alzheimer's Disease Blood Diagnostic Product Offered
Table 78. Fujirebio Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Fujirebio Main Business
Table 80. Fujirebio Latest Developments
Table 81. Amoneta Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 82. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 83. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Amoneta Diagnostics Main Business
Table 85. Amoneta Diagnostics Latest Developments
Table 86. MagQu Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 87. MagQu Alzheimer's Disease Blood Diagnostic Product Offered
Table 88. MagQu Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. MagQu Main Business
Table 90. MagQu Latest Developments
Table 91. Vazyme Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 92. Vazyme Alzheimer's Disease Blood Diagnostic Product Offered
Table 93. Vazyme Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Vazyme Main Business
Table 95. Vazyme Latest Developments
Table 96. KingMed Diagnostics Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 97. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product Offered
Table 98. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. KingMed Diagnostics Main Business
Table 100. KingMed Diagnostics Latest Developments
Table 101. Anqun Bioengineering Details, Company Type, Alzheimer's Disease Blood Diagnostic Area Served and Its Competitors
Table 102. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product Offered
Table 103. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Anqun Bioengineering Main Business
Table 105. Anqun Bioengineering Latest Developments
LIST OF FIGURES
Figure 1. Alzheimer's Disease Blood Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Alzheimer's Disease Blood Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Alzheimer's Disease Blood Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Alzheimer's Disease Blood Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type in 2023
Figure 10. Alzheimer's Disease Blood Diagnostic in Early Diagnosis
Figure 11. Global Alzheimer's Disease Blood Diagnostic Market: Early Diagnosis (2019-2024) & ($ millions)
Figure 12. Alzheimer's Disease Blood Diagnostic in Clinical Research
Figure 13. Global Alzheimer's Disease Blood Diagnostic Market: Clinical Research (2019-2024) & ($ millions)
Figure 14. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application in 2023
Figure 15. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Player in 2023
Figure 16. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Figure 17. Americas Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 18. APAC Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 19. Europe Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 21. Americas Alzheimer's Disease Blood Diagnostic Value Market Share by Country in 2023
Figure 22. United States Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region in 2023
Figure 27. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Figure 28. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Figure 29. China Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 33. India Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Country in 2023
Figure 36. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Figure 37. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Figure 38. Germany Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 39. France Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 52. APAC Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 53. Europe Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 55. United States Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 56. Canada Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 57. Mexico Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 58. Brazil Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 59. China Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 60. Japan Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 61. Korea Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 63. India Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 64. Australia Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 65. Germany Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 66. France Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 67. UK Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 68. Italy Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 69. Russia Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 70. Egypt Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 71. South Africa Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 72. Israel Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 73. Turkey Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 75. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Alzheimer's Disease Blood Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Alzheimer's Disease Blood Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Alzheimer's Disease Blood Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Alzheimer's Disease Blood Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type in 2023
Figure 10. Alzheimer's Disease Blood Diagnostic in Early Diagnosis
Figure 11. Global Alzheimer's Disease Blood Diagnostic Market: Early Diagnosis (2019-2024) & ($ millions)
Figure 12. Alzheimer's Disease Blood Diagnostic in Clinical Research
Figure 13. Global Alzheimer's Disease Blood Diagnostic Market: Clinical Research (2019-2024) & ($ millions)
Figure 14. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application in 2023
Figure 15. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Player in 2023
Figure 16. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Figure 17. Americas Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 18. APAC Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 19. Europe Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size 2019-2024 ($ millions)
Figure 21. Americas Alzheimer's Disease Blood Diagnostic Value Market Share by Country in 2023
Figure 22. United States Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region in 2023
Figure 27. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Figure 28. APAC Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Figure 29. China Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 33. India Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Country in 2023
Figure 36. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Figure 37. Europe Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Figure 38. Germany Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 39. France Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Alzheimer's Disease Blood Diagnostic Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 52. APAC Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 53. Europe Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 55. United States Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 56. Canada Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 57. Mexico Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 58. Brazil Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 59. China Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 60. Japan Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 61. Korea Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 63. India Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 64. Australia Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 65. Germany Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 66. France Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 67. UK Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 68. Italy Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 69. Russia Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 70. Egypt Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 71. South Africa Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 72. Israel Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 73. Turkey Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Alzheimer's Disease Blood Diagnostic Market Size 2025-2030 ($ millions)
Figure 75. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Alzheimer's Disease Blood Diagnostic Market Size Market Share Forecast by Application (2025-2030)
